We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTY
376
Getty Realty Corp
GTY
$2.06B
$1.08M 0.03%
+29,952
New +$1.05M
ON icon
377
ON Semiconductor
ON
$19.3B
$1.03M 0.02%
+12,500
New +$950K
IMUX icon
378
Immunic
IMUX
$212M
$1.02M 0.02%
+68,613
New +$1.27M
IPVF
379
DELISTED
InterPrivate III Financial Partners Inc.
IPVF
$1.01M 0.02%
+99,050
New +$1.01M
RNG icon
380
RingCentral
RNG
$5.35B
$1M 0.02%
+32,655
New +$1.17M
COLD icon
381
Americold
COLD
$4.12B
$1M 0.02%
+35,152
New +$1.05M
RYTM icon
382
Rhythm Pharmaceuticals
RYTM
$7.82B
$1,000K 0.02%
+56,050
New +$1.41M
RIGL icon
383
Rigel Pharmaceuticals
RIGL
$758M
$1,000K 0.02%
+75,751
New +$1.2M
THRX
384
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$983K 0.02%
+110,715
New +$1.09M
SPRY icon
385
ARS Pharmaceuticals
SPRY
$606M
$976K 0.02%
+149,915
New +$1.15M
IRON icon
386
Disc Medicine
IRON
$2.96B
$969K 0.02%
+45,750
New +$1.02M
ARVN icon
387
Arvinas
ARVN
$570M
$966K 0.02%
+35,350
New +$1.12M
LRMR icon
388
Larimar Therapeutics
LRMR
$425M
$963K 0.02%
+212,494
New +$1.11M
DISH
389
PUT
DELISTED
DISH Network Corp.
DISH
$963K 0.02%
+126,400
New +$1.59M
HWEL
390
DELISTED
Healthwell Acquisition Corp. I Class A Common Stock
HWEL
$959K 0.02%
+94,525
New +$951K
ROCL
391
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$956K 0.02%
+92,674
New +$949K
IVCP
392
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$956K 0.02%
+92,674
New +$949K
UBER icon
393
Uber
UBER
$153B
$946K 0.02%
+29,830
New +$946K
ITOS
394
DELISTED
iTeos Therapeutics
ITOS
$943K 0.02%
+69,300
New +$1.24M
MNK
395
DELISTED
Mallinckrodt plc
MNK
$943K 0.02%
+129,376
New +$1.04M
SPY icon
396
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$936K 0.02%
+440,000
New +$176M
ACAH
397
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$933K 0.02%
+92,674
New +$935K
ARE icon
398
Alexandria Real Estate Equities
ARE
$8.41B
$914K 0.02%
+7,280
New +$1.07M
AMZN icon
399
Amazon
AMZN
$3T
$914K 0.02%
+8,847
New +$855K
FUSN
400
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$912K 0.02%
+242,026
New +$953K

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.